Embody review

Embody is a platform connecting patients with medical services and pharmacy fulfillment. Its GLP-1 pages name OpenLoop Health as the clinical network and separately list pharmacy partners. This makes the organizations behind the service more visible, but it is not an external license check for a particular prescriber or dispensing site. The platform says the program bundles medication, clinical review and support without a separate membership charge. Ask what your selected bundle includes and what can generate another charge, especially testing, a change of treatment or a different pharmacy. Payment does not guarantee that a clinician will prescribe the requested medicine or approve a particular dose.

The homepage and individual GLP-1 product pages advertise different starting figures. Plans are described with four-, twelve-, twenty-four- and fifty-two-week lengths, while a dedicated product page calls its shortest offer a one-month supply. Those labels do not establish the exact recurring charge dates. A supply duration, a plan commitment and a calendar-month subscription are different facts. Until a written checkout schedule resolves the relationship, the prices here remain unquoted for monthly comparison. Do not infer a particular annual payment count from the word month or a four-week plan name. Request the full charge today, the supply covered, the next charge date and the renewal amount.

The GLP-1 FAQ promotes the same price across doses within a selected medication plan. That can be useful when comparing titration costs, but it does not guarantee continued clinical approval or a transfer at an existing dose. The product pages make the clinician responsible for final medication selection and dose changes. If switching from another service, provide the actual prescription history and ask whether new monitoring is needed. Compounded semaglutide or tirzepatide is not an FDA-approved product. Approval and clinical results for an approved brand do not establish identical safety, effectiveness or quality for the preparation a partner pharmacy supplies.

The longevity catalog also needs a specific quote. Sermorelin, NAD+ and glutathione appeared in the reviewed intake pathways, but the readable landing pages do not establish current renewal charges, commitments or all shipping conditions. Earlier intake figures should not become an unqualified monthly headline when those terms cannot be confirmed. NAD+ injection and nasal spray are different formulations, and a similar advertised price would not establish equivalent evidence or absorption. For sermorelin or glutathione, ask about the proposed route, monitoring and actual pharmacy label. The existence of a program is not evidence of improved sleep, skin, energy or healthy aging.

The refund policy is unusually restrictive in practical terms. Payments become final at purchase, including unused portions of multi-month bundles, incomplete intake and a decision not to accept treatment. The policy describes the bundle as a single indivisible purchase rather than separately refundable monthly shipments. Its stated exception is provider-initiated medical disqualification: unused value is returned after deducting services already rendered, which can include clinical review, consultation, prescriptions, medication and labs. That is not the same as a guaranteed full refund if no medicine is delivered. Ask which deductions can apply before paying for a long commitment.

To stop the next renewal, the policy requires a cancellation request at least 72 hours before the billing date, through the patient portal, email or phone. A later request can leave another non-refundable charge before cancellation takes effect. Damaged or incorrect medication has a stated replacement remedy, with immediate reporting and evidence for damage; that should not be described as a cash-refund guarantee. Current product copy also says access may vary by state, so confirm your own treatment’s availability rather than relying on an old state exclusion or assuming nationwide delivery. Keep the written schedule and confirmation of cancellation, and identify who handles urgent clinical questions between routine messages.